Hydroxyurea and Other Disease Modifying Therapies for Sickle Cell Disease

Hydroxyurea and Other Disease Modifying Therapies for Sickle Cell Disease
Presented by ASH in 2013, adapted in part from: Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Note: to order larger quantities please send a detailed request to quality@hematology.org.

Pricing

Purchase Options List Price Members Price
Print $0.00 $0.00

Hydroxyurea and Other Disease Modifying Therapies for Sickle Cell Disease

Orders normally ship on the Friday after the order is placed. Please keep this in mind when selecting your shipping method.

Questions?
Contact ASH Customer Service at 866-828-1231 (U.S. inquiries only), 202-776-0544, or email customerservice@hematology.org.